Patients with skin cancer in England and Wales will be first in Europe to benefit from new treatment

Patients with skin cancer in England will be the first in Europe to have access to new drugs which can stall progression of advanced (unresectable or metastatic) melanoma by an average of eight months, compared with standard treatment.
Source: Care Feeds

Our Office is Open from 9 am-5 pm Mon to Fri

ICare Nottingham Ltd

172 Derby Road,

Lenton Nottingham

NG7 1LR

T: 0115 9782403

Email: a.hussain@icarenottingham.co.uk

Email: recruitment@icarenottingham.co.uk

qcs
qcs
qcs